EASL-AASLD Joint Meeting on Alcoholic Liver Disease and Alcoholic Hepatitis 2017

EASL-AASLD Joint Meeting on Alcoholic Liver Disease and Alcoholic Hepatitis is organized by European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Diseases (AASLD) and would be held during Sep 30 - Oct 01, 2017 at Pullman London St Pancras, London, England, United Kingdom.

Why Should Attend?
Alcohol related liver disease remains the most important cause of liver disease morbidity and mortality in Europe and North America and is therefore relevant to all hepatologists.

Conference Objectives:
• Attendees will be equipped with the most up-to-date evidence based practice information relevant to patients with alcohol related liver disease
• The attendees will be familiar with the most important controversies in the field and how the experts are addressing these issues
• The attendees will become aware of the rational behind new endpoints in clinical trials
• Debate and set endpoints in clinical trials
• Discuss and generate guidelines of best practice in alcohol related liver disease

During the EASL-AASLD joint meeting on "Definition, therapeutic advances and clinical endpoints in alcoholic liver disease and alcoholic hepatitis" topics on public health, diagnostic definitions, therapeutic advances and clinical endpoints in alcohol related liver disease and alcoholic hepatitis will be discussed. Alcohol related liver disease (ALD) is the most prevalent cause of advanced liver disease and liver related mortality in Western countries.

This conference will be a unique occasion to interact with experts and top-researchers, to get new ideas but also to contribute in the field of therapeutic development in ALD and alcoholic hepatitis.